---
layout: post
title: "康缘药业枣柏安神颗粒临床试验获批"
date: 2022-04-14 17:58:59 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.600557" data-code="600557|1|1" data-code2="600557|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600557&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600557_0" data-code="K 600557|1|1" data-code2="K 600557|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>康缘药业公告，公司近日收到国家药品监督管理局签发的枣柏安神颗粒《药物临床试验批准通知书》。枣柏安神颗粒处方源于临床经验方，功能主治为养血安魂，清热除烦，用于肝血不足，虚热内扰证之失眠。<br /></p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204142343704566>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)